AFT — AFT Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- NZ$482.38m
- NZ$525.04m
- NZ$254.71m
Brief: AFT Pharmaceuticals Reports Double Digit Revenue Growth In 1H FY27
NZ's AFT Pharmaceuticals gains most in over 2 weeks on strong half-year results
Brief: AFT Pharmaceuticals Enters Exclusive Development, License And Supply Agreement With Mikasaseiyaku
NZ's AFT Pharma rises to near 1-month high on Japan licensing deal for Maxigesic IV
Brief: AFT Pharmaceuticals Says Scomara Tentative Approval By US FDA
Brief: AFT Pharmaceuticals Says FDA Allows Injectable Iron Project Clinical Study
NZ's AFT Pharmaceuticals gains as US FDA clears path for Phase III iron trial
NZ's AFT Pharmaceuticals rises most in six months on upbeat FY earnings, forecast
Brief: AFT Pharmaceuticals Targets FY27 Revenue Above NZ$300 Mln
Brief: AFT Pharmaceuticals Declares Final Dividend of 2.5 NZ Cents Per Share
Brief: Aft Pharmaceuticals Names Stuart Houliston CFO
NZ's AFT Pharmaceuticals gains most in 4 months on FY26 earnings outlook upgrade
Brief: AFT Pharmaceuticals Provides March Quarter Investor Update
Brief: AFT Pharmaceuticals Says CFO-Designate Simon Bosley Will Not Take Up Role
Brief: AFT Pharmaceuticals Notes A Court Of Appeal Judgment
NZ's AFT Pharmaceuticals hits over 1-1/2-year high on upbeat half-year results
Brief: AFT Pharmaceuticals Logs H1 Net Income NZD 2.7 Mln
Brief: AFT Pharmaceuticals Says CFO Malcolm Tubby To Retire
Brief: AFT Pharmaceuticals On Track For NZ$300M Fy27 Revenue